Dutch food and nutrition group Royal Numico has announced that it has reached an agreement on the sale of its US nutritional supplements company GNC to US private investment firm Apollo Management for US$750m.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The transaction is subject to customary regulatory approvals and is expected to be completed in the fourth quarter of 2003, the company said.
“With the intended sale of GNC, Numico will sharpen its focus on its core businesses, baby food and clinical nutrition, to achieve the objective of becoming a high-growth, high-margin specialised nutrition company,” said Jan Bennink, CEO of Numico.
“The decision to divest GNC is based on an assessment of our business strategy, where we see limited synergies with our current core businesses. The divestment has many advantages for Numico: it will significantly reduce the risk level, both financially and operationally, provides us with more financial flexibility and allows management to focus completely on maximising profitable growth in both baby food and clinical nutrition,” Bennink said.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
